91Ӱ

Member News

Gamble–George, Garneau–Tsodikova represented in statuary form

The IF/THEN ambassadors are among 125 women in STEM featured in exhibit
Laurel Oldach
Dec. 27, 2021

People strolling through the garden of a luxury mall in Dallas between May and October this year may have been surprised to encounter a party of lifesize, bright orange statues of living women in science on its lawn.

The statues were of the 125 ambassadors of the IF/THEN project, sponsored by Texas philanthropist and business owner Lyda Hill in partnership with the American Association for the Advancement of Science, 500 Women in STEM and other groups.

IF/THEN aims to increase representation of women in the sciences, technology, engineering and medicine. Two of the statues honor who also are members of the 91Ӱ and Molecular Biology: and .

IF/THEN Collection
Joyonna Gamble–George was a premed biochemistry major at Xavier University of Louisiana, earned a master's in health administration from the University of South Florida and then earned her Ph.D. in neuroscience at Vanderbilt University. She's now a postdoc at New York University.
Sylvie Garneau–Tsodikova attended Université Laval in Québec for her undergraduate and master's degrees in chemistry and the University of Alberta in Edmonton, Canada, for her Ph.D. in chemistry. She was a postdoctoral researcher in Christopher T. Walsh's lab at Harvard Medical School before joining the University of Michigan as an assistant professor and later the University of Kentucky as an associate professor.

Gamble–George is a postdoctoral researcher at New York University's nursing college. She earned her Ph.D. in neuroscience at Vanderbilt University in 2016, studying stress signaling, and pursued postdoctoral research in neuroscience at the University of Florida before accepting a AAAS science and technology policy fellowship based at the National Institutes of Health.

She has been at NYU since 2020, studying behavioral health, and recently published on how the pandemic has affected drinking behavior among New Yorkers. Gamble–George also is the co-founder and chief scientific officer of a Florida-based biotechnology company developing wearable technologies that aim to use artificial intelligence to predict events such as heart attacks before they occur.

Garneau–Tsodikova is a professor of pharmaceutical sciences and assistant vice president for research at the University of Kentucky. Her lab studies the biosynthesis of polyketides and other nonribosomal peptides, which can be used as anticancer and antibacterial agents. She also is interested in developing new antimicrobial agents that can overcome resistance in bacteria and fungi.

Garneau–Tsodikova earned her Ph.D. at the University of Alberta and pursued postdoctoral research at Harvard Medical School. Before joining the faculty at the University of Kentucky, she was an assistant professor at the University of Michigan. Her work was on CBS Mission Unstoppable.

Enjoy reading 91ӰToday?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from 91ӰToday

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

91Ӱmembers recognized as Allen investigators
Member News

91Ӱmembers recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, 91Ӱeducators say
Advice

AI can be an asset, 91Ӱeducators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

91Ӱundergraduate education programs foster tomorrow’s scientific minds
Feature

91Ӱundergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.